Clinical Trials
135 trialsSelpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
CD70-targeted immunoPET Imaging of Malignant Cancers
RenJi Hospital
Digital Peer Navigation for Adolescents and Young Adults With Cancer
University Health Network, Toronto
Agriculture Health Study
National Institutes of Health Clinical Center (CC)
Indocyanine Green (ICG) Guided Tumor Resection
St. Jude Children's Research Hospital
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
CLOVER-2
Cellectar Biosciences, Inc.
CALySSEY
Baylor College of Medicine
SELECT-CAR-NK
Essen Biotech
CONFIRM
Brigham and Women's Hospital
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
PREPARE
Institut Bergonié
AYA STEPS
Duke University
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center
CAMPERR
Adela, Inc
ON-5001
OncoNano Medicine, Inc.
LIBERATE
University Health Network, Toronto
DETERMINE
Cancer Research UK
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
EARN
Washington University School of Medicine
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers
Trishula Therapeutics, Inc.
PRIORITY
Institut Bergonié
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Novartis
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
IIT2020-20-SHIRAZIP-WALK: Nature Walks
Cedars-Sinai Medical Center
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Cedars-Sinai Medical Center
FUTURE
Assistance Publique Hopitaux De Marseille
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
National Cancer Institute (NCI)
MOHCCN-O
University Health Network, Toronto
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab
RAPT Therapeutics, Inc.
Survivorship
University of Modena and Reggio Emilia
QUANTUM
VitaMed Research LLC
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Cedars-Sinai Medical Center
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
UVA-Gen001
University of Virginia
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
THERMOEDEME
Association Francaise pour la Recherche Thermale
Early Rehabilitation of Cancer Patients
Haukeland University Hospital
A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors
Huashan Hospital
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
Rutgers, The State University of New Jersey
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
National Institutes of Health Clinical Center (CC)
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Eastern Cooperative Oncology Group
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Fate Therapeutics
A Study of PNT2258 in Patients With Advanced Solid Tumors
Sierra Oncology LLC - a GSK company
RESTORE
Blue Note Therapeutics